Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Researchers develop new compound to block therapeutic target in aggressive blood cancer

Researchers develop new compound to block therapeutic target in aggressive blood cancer

How genetic differences in Epstein-Barr virus strains alter the way it behaves

How genetic differences in Epstein-Barr virus strains alter the way it behaves

Study uncovers gene that hides tumor cells from immunotherapy

Study uncovers gene that hides tumor cells from immunotherapy

Mathematical model helps quantify metastatic cell behavior

Mathematical model helps quantify metastatic cell behavior

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers create new device to see if targeted cancer therapy is working

AI-enabled device detects if targeted chemotherapy is working

AI-enabled device detects if targeted chemotherapy is working

Gene modulation goes wireless hacking the "boss gene"

Gene modulation goes wireless hacking the "boss gene"

Sports playbook can help generate more accurate prognoses for cancer patients

Sports playbook can help generate more accurate prognoses for cancer patients

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Multiple Sclerosis patients may have greater risk of developing cancer

Multiple Sclerosis patients may have greater risk of developing cancer

Study solves mysteries of complex microRNA oncogenes

Study solves mysteries of complex microRNA oncogenes

Promising new approaches in the fight against brain metastasis

Promising new approaches in the fight against brain metastasis

Interim scan during therapy helps guide prostate cancer treatment, shows research

Interim scan during therapy helps guide prostate cancer treatment, shows research

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Chemotherapy can wreak havoc on the heart

Chemotherapy can wreak havoc on the heart

Curing cancer: easy politics, difficult science

Curing cancer: easy politics, difficult science

Cytek Biosciences unveils advanced five-laser flow cytometer

Cytek Biosciences unveils advanced five-laser flow cytometer

Research findings lead to new clinical trial for people with myelofibrosis

Research findings lead to new clinical trial for people with myelofibrosis

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development